A Phase III Clinical Study to Evaluate the Efficacy and Safety of GZR18 Injection in Subjects With Type 2 Diabetes Mellitus and Poor Blood Glucose Control by Diet and Exercise

Phase 3 Active not recruiting 274 enrolled Gan & Lee Pharmaceuticals.

RandomizedParallel-groupTriple-blindTreatment

Summary

The main purpose of this study is to investigate the Efficacy and Safety of GZR18 Injection in Chinese Subjects with Type 2 Diabetes Mellitus and Poor Blood Glucose Control by Diet and Exercise

Timeline

Start: 2025-01-16
Primary completion: 2026-08-07
Completion: 2027-03-10

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Bofanglutide	Protein / enzyme biologic	—	Subcutaneous

A Phase III Clinical Study to Evaluate the Efficacy and Safety of GZR18 Injection in Subjects With Type 2 Diabetes Mellitus and Poor Blood Glucose Control by Diet and Exercise

Summary

Timeline

Drugs

Indications